Research and Development Facility
LEXIGEN PHARMACEUTICALS CORPORATION
Multi-phased pharmaceutical R&D project, anticipated to total approximately 318,000 SF. Phase I consists of a 17,000 SF pilot plant and a 56,000 SF, 2-story Research and Development Headquarters building. Subsequent phases will include three additional R&D buildings and an 80,000 SF processing facility. In addition, 600 parking spaces will be accommodated on site in a phased structured parking facility.
|< Previous Project||All Projects||Next Project >|